/SEDANA.ST

SEDANA.ST Stock - Sedana Medical AB (publ)

Q: What is the analyst price target for SEDANA.ST?

Analyst price target information is not currently available for SEDANA.ST.

Q: What is SEDANA.ST's market cap?

Market capitalization information is not currently available for SEDANA.ST.

Healthcare|Medical - Devices|STO

$9.92-4.62%

$0.48 (-4.62%) • Dec 23

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $10.91

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for SEDANA.ST

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.09

52W High$20.30

52W Low$6.65

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$178.75M	$153.87M	$122.86M	$159.15M	$141.77M
Gross Profit	$126.14M	$108.98M	$86.07M	$106.71M	$88.90M
Gross Margin	70.6%	70.8%	70.1%	67.0%	62.7%
Operating Income	$-50,767,000	$-65,547,000	$-103,934,000	$-61,197,000	$-21,541,000
Net Income	$-10,674,000	$-59,612,000	$-73,507,000	$-57,966,000	$-27,139,000
Net Margin	-6.0%	-38.7%	-59.8%	-36.4%	-19.1%
EPS	$-0.11	$-0.60	$-0.74	$-0.62	$-0.30

Company Overview

Sedana Medical AB (publ), a medical technology company, develops, markets, and sells medical devices in Sweden and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-, which are disposable medical devices that enables the administration of volatile anesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; FlurAbsorb and FlurAbsorb-S, which are active carbon filters to capture waste anaesthetic gases from the exhaust of the ventilator; FlurAbsorb accessory kit comprising accessories to connect the exhaust of the ventilator and the gas monitor to the FlurAbsorb/FlurAbsorb-S; and FlurAbsorb mount to hold the filter during scavenging of anesthetic gas. It also provides AMG-06 Gas Monitor for continuous non-invasive sidestream monitoring of CO2 and anaesthetics concentration in inspired and expired gases; Sedaconda Filling Adapter, a single-use device for safe and easy extraction of isoflurane from a Sedaconda bottle to a Sedaconda Syringe; and various accessories comprising DRYLINE II Water Traps, WaterLock 2 water trap, Nafion Dryer Tubing, and Respiratory Gas Monitoring Line. Sedana Medical AB (publ) was founded in 1999 and is headquartered in Danderyd, Sweden.

Visit Website

Earnings History & Surprises

SEDANA.ST

Beat Rate

61%

Last 18 quarters

Avg Surprise

+10.2%

EPS vs Estimate

Beats / Misses

11/7

Last 12 quarters

Latest EPS

$-0.13

Q4 2025

EPS Surprise History

Q1 24

-153.3%

$-0.38vs$-0.15

Q2 24

+275.0%

$0.21vs$-0.12

Q3 24

-38.5%

$-0.18vs$-0.13

Q4 24

-22.2%

$-0.22vs$-0.18

Q1 25

+200.0%

$0.09vs$-0.09

Q2 25

-300.0%

$-0.24vs$-0.06

Q3 25

+21.3%

$-0.13vs$-0.17

Q4 25

-78.6%

$-0.13vs$-0.07

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 4, 2026	—	—	—	—
Q1 2026	Feb 11, 2026	—	—	—	—
Q4 2025	Oct 24, 2025	$-0.07	$-0.13	-78.6%	✗ MISS
Q3 2025	Jul 18, 2025	$-0.17	$-0.13	+21.3%	✓ BEAT
Q2 2025	May 6, 2025	$-0.06	$-0.24	-300.0%	✗ MISS
Q1 2025	Feb 13, 2025	$-0.09	$0.09	+200.0%	✓ BEAT
Q4 2024	Oct 24, 2024	$-0.18	$-0.22	-22.2%	✗ MISS
Q3 2024	Jul 23, 2024	$-0.13	$-0.18	-38.5%	✗ MISS
Q2 2024	Apr 25, 2024	$-0.12	$0.21	+275.0%	✓ BEAT
Q1 2024	Feb 15, 2024	$-0.15	$-0.38	-153.3%	✗ MISS
Q4 2023	Oct 26, 2023	$-0.20	$-0.07	+65.0%	✓ BEAT
Q3 2023	Jul 21, 2023	$0.00	$0.01	+133.1%	✓ BEAT
Q2 2023	Apr 27, 2023	$-0.22	$-0.16	+27.3%	✓ BEAT
Q1 2023	Feb 16, 2023	$-0.15	$-0.36	-140.0%	✗ MISS
Q4 2022	Oct 25, 2022	$-0.29	$-0.08	+72.4%	✓ BEAT
Q3 2022	Jul 21, 2022	$-0.23	$-0.11	+52.2%	✓ BEAT
Q2 2022	Apr 28, 2022	$-0.26	$-0.19	+26.9%	✓ BEAT
Q1 2022	Feb 17, 2022	$-0.24	$-0.18	+25.0%	✓ BEAT
Q4 2021	Nov 4, 2021	$-0.24	$-0.17	+29.2%	✓ BEAT
Q3 2021	Aug 19, 2021	$-0.17	$-0.19	-11.8%	✗ MISS

Frequently Asked Questions about SEDANA.ST

What is SEDANA.ST's current stock price?

Sedana Medical AB (publ) (SEDANA.ST) is currently trading at $9.92 per share. The stock has moved -4.62% today.

What is the analyst price target for SEDANA.ST?

No analyst price targets are currently available for this stock.

What sector is Sedana Medical AB (publ) in?

Sedana Medical AB (publ) operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the STO exchange.

What is SEDANA.ST's market cap?

Sedana Medical AB (publ) has a market capitalization of $0.99 billion, making it a small-cap company.

Does SEDANA.ST pay dividends?

No, Sedana Medical AB (publ) does not currently pay a dividend to shareholders.